<DOC>
	<DOCNO>NCT02711176</DOCNO>
	<brief_summary>This study conduct investigate whether efficacy single-dose triple therapy ( Esomeprazole 40 mg , Tinidazole 1 g , Levofluxacine 500 mg ) 14 day superior double-dose lansoprazole 30 mg , amoxicillin 1 g clarithromycin 500 mg 14 day treatment H pylori infection .</brief_summary>
	<brief_title>Comparison Daily Single Dose Triple Conventional Triple Therapies Helicobacter Pylori Infection</brief_title>
	<detailed_description>Multiple regimen evaluate H. pylorus therapy randomize control trial The treatment regimen select must effective , consideration cost , side effect , ease administration also take account . Despite number study , optimal therapeutic regimen yet define . The regimen commonly recommend first line treatment H. pylorus triple therapy PPI , amoxicillin clarithromycin 14 day . However , multi-drug application associate remarkable side effect uncommon able complete treatment course . Thus , treatment failure associate H. pylorus strain resistant commonly use antibiotic . This study conduct investigate whether efficacy single-dose triple therapy ( Esomeprazole 40 mg , Tinidazole 1 g , Levofluxacine 500 mg ) 14 day superior double-dose lansoprazole 30 mg , amoxicillin 1 g clarithromycin 500 mg 14 day treatment H pylori infection .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Tinidazole</mesh_term>
	<criteria>The patient prove H. pylori infection follow three method Positive rapid urease test Histologic evidence H. pylorus modify Giemsa stain Positive stool Antigen Test Patients receive eradication therapy H. pylorus infection , previously H. pylori eradication failure poor compliance The administration antibiotic consumption bismuth salt within 4 week administration proton pump inhibitor ( PPI ) within 2 week Advanced gastric cancer malignancy Abnormal liver function liver cirrhosis Abnormal renal function chronic kidney disease Other severe concurrent diseases Previous allergic reaction study drug Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>